Regulation of hypothalamic corticotropin-releasing hormone transcription by elevated glucocorticoids

Molecular Endocrinology

Volumn 27, Issue 11, 2013, Pages 1796-1807

  Evans, Andrew N ^a,b   Liu, Ying ^a   MacGregor, Robert ^a   Huang, Victoria ^a   Aguilera, Greti ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; FORSKOLIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HETEROGENEOUS NUCLEAR RNA; PER1 PROTEIN; PROTEIN; TRANSDUCER OF REGULATED CREB ACTIVITY 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL LINE 4B; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN RELEASING FACTOR GENE; EMBRYO; GENE; GENE REPRESSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMOBILIZATION STRESS; MALE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIMARY CULTURE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSDUCER; WESTERN BLOTTING;

AFFERENT PATHWAYS; ANIMALS; CELL LINE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 84886379332     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1095     Document Type: Article

References (60)

1. Aguilera G, Liu Y. The molecular physiology of CRH neurons. Front Neuroendocrinol. 2012;33:67-84.
2. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev. 1986;7:351-378.
3. Claes S. Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med (Helsinki). 2004;36:50-61.
4. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-179.
5. Munck A, Náray-Fejes-Tóth A. Glucocorticoids and stress: permissive and suppressive actions. Ann NY Acad Sci. 1994;746:115-130; discussion 131-133.
6. Dallman MF. Fast glucocorticoid actions on brain: back to the future. Front Neuroendocrinol. 2005;26:103-108.
7. Myers B, McKlveen J, Herman J. Neural regulation of the stress response: the many faces of feedback. Cell Mol Neurobiol. 2012; 32:683-694.
8. Dallman MF, Akana SF, Levin N, et al. Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann NY Acad Sci. 1994;746:22-28; discussion 32-32, 64-67.
9. Lightman SL, Young WS 3rd. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J Physiol. 1988;403:511-523.
10. Ma XM, Aguilera G. Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids. Endocrinology. 1999;140:5642-5650.
11. Makino S, Smith MA, Gold PW. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology. 1995;136:3299-3309.
12. Aguilera G, Kiss A, Liu Y, Kamitakahara A. Negative regulation of corticotropin releasing factor expression and limitation of stress response. Stress. 2007;10:153-161.
13. Harbuz MS, Lightman SL. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin A messenger RNA. Neuropeptides. 1989;14:17-20.
14. Kovács KJ, Makara GB. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Res. 1988;474:205-210.
15. Sawchenko PE. Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res. 1987;403:213-223.
16. Kretz O, Reichardt HM, Schütz G, Bock R. Corticotropin-releasing hormone expression is the major target for glucocorticoid feedbackcontrol at the hypothalamic level. Brain Res. 1999;818:488-491.
17. Fenoglio KA, Brunson KL, Avishai-Eliner S, Chen Y, Baram TZ. Region-specific onset of handling-induced changes in corticotrop-in-releasing factor and glucocorticoid receptor expression. Endocrinology. 2004;145:2702-2706.
18. Liposits Z, Uht RM, Harrison RW, Gibbs FP, Paull WK, Bohn MC. Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF). Histochemistry. 1987;87:407-412.
19. Guardiola-Diaz HM, Kolinske JS, Gates LH, Seasholtz AF. Negative glucorticoid regulation of cyclic adenosine 3′ 5′-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol Endocrinol. 1996;10:317-329.
20. Malkoski SP, Handanos CM, Dorin RI. Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol Cell Endocrinol. 1997;127:189-199.
21. Yamamori E, Iwasaki Y, Taguchi T, et al. Molecular mechanisms or corticotropin-releasing hormone gene repression by glucocorticoid in BE(2)C neuronal cell line. Mol Cell Endocrinol. 2007;264: 142-148.
22. Malkoski SP, Dorin RI. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol. 1999;13:1629-1644.
23. Van LP, Spengler DH, Holsboer F. Glucocorticoid repression of 3′5′-cyclic-adenosine monophosphate-dependent human corticotropin-releasing-hormone gene promoter activity in a transfected mouse anterior pituitary cell line. Endocrinology. 1990;127:1412-1418.
24. Yao M, Schulkin J, Denver RJ. Evolutionarily conserved glucocorticoid regulation of corticotropin-releasing factor expression. Endocrinology. 2008;149:2352-2360.
25. Nicholson RC, King BR, Smith R. Complex regulatory interactions control CRH gene expression. Front Biosci. 2004;9:32-39.
26. Liu Y, Kamitakahara A, Kim AJ, Aguilera G. Cyclic adenosine 3′5′-monophosphate responsive element binding protein phosphorylation is required but not sufficient for activation of corticotropin-releasing hormone transcription. Endocrinology. 2008;149: 3512-3520.
27. Kageyama K, Suda T. Transcriptional regulation of hypothalamic corticotropin-releasing factor gene. Vitam Horm. 2010;82:301-317.
28. Nikodemova M, Kasckow J, Liu H, Manganiello V, Aguilera G. Cyclic adenosine 3′-5′-monophosphate regulation of corticotropin-releasing hormone promoter activity in AtT-20 Cells and in a transformed hypothalamic cell line. Endocrinology. 2003;144:1292-1300.
29. Liu Y, Coello AG, Grinevich V, Aguilera G. Involvement of transducer of regulated cAMP response element-binding protein activity on corticotropin releasing hormone transcription. Endocrinology. 2010;151:1109-1118.
30. Watts AG. Glucocorticoid regulation of peptide genes in neuroendocrine CRH neurons: a complexity beyond negative feedback. Front Neuroendocrinol. 2005;26:109-130.
31. Kageyama K, Akimoto K, Suda T. Corticotrophin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells. J Neuroendocrinol. 2010;22:971-978.
32. Adler GK, Smas CM, Majzoub JA. Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line. J Biol Chem. 1988;263:5846-5852.
33. Jeanneteau FD, Lambert WM, Ismaili N, et al. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc Natl Acad Sci USA. 2012;109: 1305-1310.
34. Bali B, Ferenczi S, Kovács KJ. Direct inhibitory effect of glucocorticoids on corticotrophin-releasing hormone gene expression in neurones of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neuroendocrinol. 2008;20:1045-1051.
35. Grøntved L, John S, Baek S, et al. C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J. 2013;32:1568-1583.
36. Conway-Campbell BL, Sarabdjitsingh RA, McKenna MA, et al. Glucocorticoid ultradian rhythmicity directs cyclical gene pulsing of the clock gene period 1 in rat hippocampus. J Neuroendocrinol. 2010;22:1093-1100.
37. Meng QY, Chen XN, Tong DL, Zhou JN. Stress and glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex. Mol Cell Endocrinol. 2011;342:54-63.
38. Przybycien-Szymanska MM, Mott NN, Pak TR. Alcohol dysregulates corticotropin-releasing-hormone (CRH) promoter activity by interfering with the negative glucocorticoid response element (nGRE). PLoS One. 2011;6:e26647.
39. Sharma D, Bhave S, Gregg E, Uht R. Dexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoter. Mol Endocrinol. 2013;27:1142-1152.
40. Liu Y, Kalintchenko N, Sassone-Corsi P, Aguilera G. Inhibition of corticotrophin-releasing hormone transcription by inducible cAMP-early repressor in the hypothalamic cell line, 4B. J Neuroendocrinol. 2006;18:42-49.
41. Hakim O, John S, Ling JQ, Biddie SC, Hoffman AR, Hager GL. Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions. J Biol Chem. 2009;284:6048-6052.
42. Paakinaho V, Makkonen H, Jääskeläinen T, Palvimo JJ. Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol Endocrinol. 2010;24:511-525.
43. So A, Chaivorapol C, Bolton E, Li H, Yamamoto K. Determinants of celland gene-specific transcriptional regulation by the glucocorticoid receptor. PLOS Genet. 2007;3:e94.
44. Légárdi G, Holzer D, Kapcala LP, Lechan RM. Glucocorticoids inhibit stress-induced phosphorylation of CREB in corticotropinreleasing hormone neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology. 1997;66:86-97.
45. Liu Y, Knobloch HS, Grinevich V, Aguilera G. Stress induces parallel changes in corticotrophin-releasing hormone (CRH) transcription and nuclear translocation of transducer of regulated cAMP response element-binding activity 2 in hypothalamic CRH neurones. J Neuroendocrinol. 2011;23:216-223.
46. Conkright MD, Canettieri G, Screaton R, et al. TORCs: transducers of regulated cREB activity. Mol Cell. 2003;12:413-423.
47. Watts AG, Sanchez-Watts G, Liu Y, Aguilera G. The distribution of messenger RNAs encoding the three isoforms of the transducer of regulated cAMP responsive element binding protein activity in the rat forebrain. J Neuroendocrinol. 2011;23:754-766.
48. Liu Y, Poon V, Sanchez-Watts G, Watts AG, Takemori H, Aguilera G. Salt-inducible kinase is involved in the regulation of corticotropin-releasing hormone transcription in hypothalamic neurons in rats. Endocrinology. 2012;153:223-233.
49. Takemori H, Okamoto M. Regulation of CREB-mediated gene expression by salt inducible kinase. J Steroid Biochem Mol Biol. 2008;108:287-291.
50. Kasckow J, Mulchahey JJ, Aguilera G, et al. Corticotropin-releasing hormone (CRH) expression and protein kinase A mediated CRH receptor signalling in an immortalized hypothalamic cell line. J Neuroendocrinol. 2003;15:521-529.
51. Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-B and the glucocorticoid receptor. Proc Natl Acad Sci USA. 2000;97:11893-11898.
52. Andrews MH, Wood SA, Windle RJ, Lightman SL, Ingram CD. Acute glucocorticoid administration rapidly suppresses basal and stress-induced hypothalamo-pituitary-adrenal axis activity. Endocrinology. 2012;153:200-211.
53. Ginsberg AB, Campeau S, Day HE, Spencer RL. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol. 2003;15:1075-1083.
54. Imaki T, Xiao-Quan W, Shibasaki T, et al. Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats. J Clin Invest. 1995;96:231-238.
55. Pacak K, Palkovits M, Kvetnansky R, et al. Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. Endocrinology. 1995;136:4814-4819.
56. Kaminski KL, Watts AG. Intact catecholamine inputs to the forebrain are required for appropriate regulation of corticotrophinreleasing hormone and vasopressin gene expression by corticosterone in the rat paraventricular nucleus. J Neuroendocrinol. 2012; 24:1517-1526.
57. Day H, Campeau S, Watson SJ JR, Akil H. Expression of 1b adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J Neurosci. 1999;19:10098-10106.
58. Feuvrier E, Aubert M, Mausset AL, et al. Glucocorticoids provoke a shift from alpha2-to alpha1-adrenoreceptor activities in cultured hypothalamic slices leading to opposite noradrenaline effect on corticotropin-releasing hormone release. J Neurochem. 1998;70: 1199-1209.
59. Boyle MP, Brewer JA, Funatsu M, et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci USA. 2005;102:473-478.
60. Arnett MG, Kolber BJ, Boyle MP, Muglia LJ. Behavioral insights from mouse models of forebrainand amygdala-specific glucocorticoid receptor genetic disruption. Mol Cell Endocrinol. 2011;336:2-5.